BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 4, 2010
View Archived Issues
alpha2A-Adrenoceptor gene polymorphism and overexpression linked to type 2 diabetes
Read More
Prostanoid DP receptor antagonist AMG-853 safe in humans
Read More
Bepreve reduces allergen-induced ocular itching, nasal congestion and rhinorrhea in phase III trials
Read More
XF-73 and XF-70 active against pathogens relevant to biodefense
Read More
Submicron budesonide formulation may innovate pediatric asthma treatment
Read More
Vaccination with autologous HIV-1-pulsed DCs feasible in HIV
Read More
Janssen presents novel dopamine and serotonin receptor antagonists
Read More
Sanofi-aventis claims new cannabinoid CB1 receptor antagonists
Read More
Boehringer Ingelheim claims novel EGFR inhibitors
Read More
Nabi stockholders approve NicVAX option and license agreement
Read More
Capstone continues phase II trial of AZX-100 in keloid scarring
Read More
Bristol-Myers Squibb and Allergan enter global agreement on ExonHit's AGN-209323
Read More
Final dose level approved in Pluristem's phase I trial of PLX-PAD
Read More
Seattle Genetics achieves milestone under antibody-drug conjugate collaboration with Genentech
Read More
Enanta nominates EDP-239 as lead development candidate for HCV
Read More
FDA approves Novo Nordisk's Norditropin FlexPro prefilled growth hormone pen
Read More
NicOx grants Bausch & Lomb worldwide rights to NCX-116
Read More
Lilly and Transition Therapeutics enter into licensing and collaboration agreement
Read More
Solasia and Kyowa Hakko Kirin license agreement for SP-01 in Asia
Read More
Lundbeck and Takeda plan phase III trials of Lu-AA21004 and Lu-AA24530
Read More
Pfizer and Medivation report phase III results on Dimebon in Alzheimer's disease
Read More
Genzyme and PTC report on phase IIb ataluren trial in nmDBMD
Read More
Chiesi identifies novel muscarinic M3 receptor antagonists
Read More
Light Sciences Oncology completes enrollment in phase III Aptocine trial in MCRC
Read More
Advanced Cell Technology's RPE cells granted FDA orphan drug status / News in Context
Read More